NCT01015833
Clinical Trial Information
Trial Number: NCT01015833 (ClinicalTrials.gov)
Disease Type:
- Gastrointestinal Neoplasm - Liver and Hepatobiliary Cancer
Trial Title:
Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Study ID:
CALGB-80802
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01015833-D1 | Dataset NCT01015833-D1-Dataset.csv (nctn_d1) is the only dataset associated with PubMed ID 31486832. This dataset contains the information for the entire primary analysis. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®